Average Co-Inventor Count = 3.18
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Institute for Pharmaceutical Discovery, LLC (11 from 13 patents)
2. Mars, Incorporated (10 from 1,194 patents)
3. Calithera Biosciences, Inc. (8 from 30 patents)
4. Thetis Pharmaceuticals LLC (5 from 13 patents)
5. The Institutes for Pharmaceutical Discovery LLC (3 from 3 patents)
6. Yale University (2 from 1,325 patents)
7. Other (1 from 832,680 patents)
8. Alinea Pharmaceuticals, Inc. (1 from 1 patent)
9. The Institute for Dibetes Discovery LLC (1 from 1 patent)
10. The Institute for Pharmaceuticals Discovery LLC (1 from 1 patent)
11. Precision Pharmaceuticals, Inc. (1 from 1 patent)
44 patents:
1. 12421257 - Compositions and methods for inhibiting group II intron RNA
2. 12054501 - Compositions and methods for inhibiting arginase activity
3. 11925688 - Compositions and methods relating to salts of specialized pro-resolving mediators
4. 11739104 - Compositions and methods for inhibiting group II intron RNA
5. 11389464 - Arginase inhibitors as therapeutics
6. 11370754 - Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
7. 11191840 - Compositions and methods relating to salts of specialized pro-resolving mediators
8. 11135298 - Compositions and methods relating to salts of specialized pro-resolving mediators
9. 11021495 - Compositions and methods for inhibiting arginase activity
10. 10906872 - Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
11. 10851118 - Compositions and methods for inhibiting arginase activity
12. 10844080 - Compositions and methods for inhibiting arginase activity
13. 10603330 - Arginase inhibitors as therapeutics
14. 10597411 - Compositions and methods for inhibiting arginase activity
15. 10538537 - Inhibitors of arginase and their therapeutic applications